| Tofacitinib Impurity 34 |
Tofacitinib Impurity 34 |
2459302-86-2 |
| (2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)phenyl)-6-(hydroxyl methyl)tetrahydro-2H-pyran-3,4,5-triol |
(2S,3R,4R,5S,6R)-2-(3-(4-ethoxybenzyl)phenyl)-6-(hydroxyl methyl)tetrahydro-2H-pyran-3,4,5-triol |
2452300-89-7 |
| EMpagliflozin iMpurity |
EMpagliflozin iMpurity |
2444010-96-0 |
| Linagliptin Impurity 33 |
Linagliptin Impurity 33 |
2443735-53-1 |
| 1H-Purine-2,6-dione, 8-bromo-3,9-dihydro-3-methyl-1-[(4-methyl-2-quinazolinyl)methyl]- |
利拉利汀杂质5 |
2428491-17-0 |
| Linagliptin Impurity 7 |
Linagliptin Impurity 7 |
2416949-69-2 |
| 1-(5-(2-fluorophenyl)-1-((1,4,5,6-tetrahydropyridin-3-yl)sulfonyl)-1H-pyrrol-3-yl)-N-methylmethanamine |
富马酸沃诺拉赞杂质U3 |
2416241-97-7 |
| Afatinib Impurity 9 |
阿法替尼杂质9 |
2413212-17-4 |
| Oseltamivir Impurity 17 |
奥司他韦杂质17 |
2413185-88-1 |
| (1R,5S,6R)-Ethyl 5-(Pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate |
(1R,5S,6R)-Ethyl 5-(Pentan-3-yloxy)-7-oxabicyclo[4.1.0]hept-3-ene-3-carboxylate |
2413185-89-2 |
| Nintedanib Impurity 50 |
尼达尼布杂质 |
2410284-90-9 |
| Nintedanib Impurity 52 |
Nintedanib Impurity 52 |
2410284-89-6 |
| Carfilzomib Impurity 34 |
Carfilzomib Impurity 34 |
2381627-87-6 |
| Lenvatinib Impurity 2 |
Lenvatinib Impurity 2 |
2380197-90-8 |
| trimer |
尼可地尔杂质07 |
2365474-05-9 |
| INDEX NAME NOT YET ASSIGNED |
巴洛沙韦杂质12 |
2365473-17-0 |
| Nicorandil Impurity 30 |
尼可地尔杂质30 |
2365472-37-1 |
| Macitentan Impurity 18 |
马西替坦杂质 13 |
2365406-85-3 |
| Tofacitinib Impurity 44 |
Tofacitinib Impurity 44 |
2374700-39-5 |
| Sacubitril Impurity 31 |
Sacubitril Impurity 31 |
2376611-98-0 |
QQ
微信
